• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

KPNB1 抑制破坏了蛋白质平衡,并触发了神经胶质瘤细胞中未折叠蛋白反应介导的细胞凋亡。

KPNB1 inhibition disrupts proteostasis and triggers unfolded protein response-mediated apoptosis in glioblastoma cells.

机构信息

Institute of Neuroscience, State Key Laboratory of Neuroscience, CAS Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, 200031, Shanghai, China.

School of Pharmacy, East China University of Science and Technology, 200237, Shanghai, China.

出版信息

Oncogene. 2018 May;37(22):2936-2952. doi: 10.1038/s41388-018-0180-9. Epub 2018 Mar 9.

DOI:10.1038/s41388-018-0180-9
PMID:29520102
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5978811/
Abstract

The nuclear import receptor karyopherin β1 (KPNB1) is involved in the nuclear import of most proteins and in the regulation of multiple mitotic events. Upregulation of KPNB1 has been observed in cancers including glioblastoma. Depletion of KPNB1 induces mitotic arrest and apoptosis in cancer cells, but the underlying mechanism is not clearly elucidated. Here, we found that downregulation and functional inhibition of KPNB1 in glioblastoma cells induced growth arrest and apoptosis without apparent mitotic arrest. KPNB1 inhibition upregulated Puma and Noxa and freed Mcl-1-sequestered Bax and Bak, leading to mitochondrial outer membrane permeabilization (MOMP) and apoptosis. Moreover, combination of Bcl-xL inhibitors and KPNB1 inhibition enhanced apoptosis in glioblastoma cells. KPNB1 inhibition promoted cytosolic retention of its cargo and impaired cellular proteostasis, resulting in elevated polyubiquitination, formation of aggresome-like-induced structure (ALIS), and unfolded protein response (UPR). Ubiquitination elevation and UPR activation in KPNB1-deficient cells were reversed by KPNB1 overexpression or inhibitors of protein synthesis but aggravated by inhibitors of autophagy-lysosome or proteasome, indicating that rebalance of cytosolic/nuclear protein distribution and alleviation of protein overload favor proteostasis and cell survival. Chronic activation of eIF2α/ATF4 cascade of UPR was responsible for the upregulation of Puma and Noxa, apoptosis and ABT-263 sensitivity. Taken together, our findings demonstrate that KPNB1 is required for proteostasis maintenance and its inhibition induces apoptosis in glioblastoma cells through UPR-mediated deregulation of Bcl-2 family members.

摘要

核输入受体载体蛋白β1(KPNB1)参与大多数蛋白质的核输入和多种有丝分裂事件的调节。在包括神经胶质瘤在内的多种癌症中观察到 KPNB1 的上调。KPNB1 的耗竭会诱导癌细胞有丝分裂停滞和凋亡,但潜在机制尚不清楚。在这里,我们发现下调和功能抑制神经胶质瘤细胞中的 KPNB1 会诱导生长停滞和凋亡,而没有明显的有丝分裂停滞。KPNB1 抑制上调 Puma 和 Noxa,并释放 Mcl-1 结合的 Bax 和 Bak,导致线粒体外膜通透性(MOMP)和凋亡。此外,Bcl-xL 抑制剂和 KPNB1 抑制的联合使用增强了神经胶质瘤细胞的凋亡。KPNB1 抑制促进了其货物的细胞质保留,并损害了细胞内的蛋白质稳态,导致多泛素化增加、形成聚集诱导结构(ALIS)和未折叠蛋白反应(UPR)。KPNB1 缺陷细胞中的泛素化升高和 UPR 激活可被 KPNB1 过表达或蛋白质合成抑制剂逆转,但可被自噬溶酶体或蛋白酶体抑制剂加重,表明细胞质/核蛋白质分布的再平衡和蛋白质过载的缓解有利于蛋白质稳态和细胞存活。UPR 中 eIF2α/ATF4 级联的慢性激活负责 Puma 和 Noxa 的上调、凋亡和 ABT-263 敏感性。总之,我们的研究结果表明,KPNB1 是维持蛋白质稳态所必需的,其抑制通过 UPR 介导的 Bcl-2 家族成员失调诱导神经胶质瘤细胞凋亡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/396f/5978811/3d9e69c89f80/41388_2018_180_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/396f/5978811/a566b194adbf/41388_2018_180_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/396f/5978811/514f48731cd2/41388_2018_180_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/396f/5978811/f6e2d294a325/41388_2018_180_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/396f/5978811/f944a01dc658/41388_2018_180_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/396f/5978811/67694eeeef71/41388_2018_180_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/396f/5978811/b228a5ffde07/41388_2018_180_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/396f/5978811/f8fcb9f03fd6/41388_2018_180_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/396f/5978811/3d9e69c89f80/41388_2018_180_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/396f/5978811/a566b194adbf/41388_2018_180_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/396f/5978811/514f48731cd2/41388_2018_180_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/396f/5978811/f6e2d294a325/41388_2018_180_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/396f/5978811/f944a01dc658/41388_2018_180_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/396f/5978811/67694eeeef71/41388_2018_180_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/396f/5978811/b228a5ffde07/41388_2018_180_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/396f/5978811/f8fcb9f03fd6/41388_2018_180_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/396f/5978811/3d9e69c89f80/41388_2018_180_Fig8_HTML.jpg

相似文献

1
KPNB1 inhibition disrupts proteostasis and triggers unfolded protein response-mediated apoptosis in glioblastoma cells.KPNB1 抑制破坏了蛋白质平衡,并触发了神经胶质瘤细胞中未折叠蛋白反应介导的细胞凋亡。
Oncogene. 2018 May;37(22):2936-2952. doi: 10.1038/s41388-018-0180-9. Epub 2018 Mar 9.
2
Targeting KPNB1 overcomes TRAIL resistance by regulating DR5, Mcl-1 and FLIP in glioblastoma cells.靶向 KPNB1 通过调节胶质母细胞瘤细胞中的 DR5、Mcl-1 和 FLIP 克服 TRAIL 耐药性。
Cell Death Dis. 2019 Feb 11;10(2):118. doi: 10.1038/s41419-019-1383-x.
3
Bim upregulation by histone deacetylase inhibitors mediates interactions with the Bcl-2 antagonist ABT-737: evidence for distinct roles for Bcl-2, Bcl-xL, and Mcl-1.组蛋白去乙酰化酶抑制剂上调Bim介导其与Bcl-2拮抗剂ABT-737的相互作用:Bcl-2、Bcl-xL和Mcl-1不同作用的证据
Mol Cell Biol. 2009 Dec;29(23):6149-69. doi: 10.1128/MCB.01481-08. Epub 2009 Oct 5.
4
KPNB1-mediated nuclear import in cancer.KPNB1 介导的癌症核输入。
Eur J Pharmacol. 2023 Sep 15;955:175925. doi: 10.1016/j.ejphar.2023.175925. Epub 2023 Jul 18.
5
Dual inhibition of Bcl-2 and Bcl-xL strikingly enhances PI3K inhibition-induced apoptosis in human myeloid leukemia cells through a GSK3- and Bim-dependent mechanism.双重抑制 Bcl-2 和 Bcl-xL 通过 GSK3 和 Bim 依赖性机制显著增强了 PI3K 抑制诱导的人髓系白血病细胞凋亡。
Cancer Res. 2013 Feb 15;73(4):1340-51. doi: 10.1158/0008-5472.CAN-12-1365. Epub 2012 Dec 12.
6
Reversal of Mutant KRAS-Mediated Apoptosis Resistance by Concurrent Noxa/Bik Induction and Bcl-2/Bcl-xL Antagonism in Colon Cancer Cells.在结肠癌细胞中通过同时诱导Noxa/Bik和拮抗Bcl-2/Bcl-xL逆转突变型KRAS介导的凋亡抗性
Mol Cancer Res. 2015 Apr;13(4):659-69. doi: 10.1158/1541-7786.MCR-14-0476. Epub 2014 Dec 29.
7
Stabilization of KPNB1 by deubiquitinase USP7 promotes glioblastoma progression through the YBX1-NLGN3 axis.去泛素化酶 USP7 通过稳定 KPNB1 促进神经胶质瘤的进展通过 YBX1-NLGN3 轴。
J Exp Clin Cancer Res. 2024 Jan 23;43(1):28. doi: 10.1186/s13046-024-02954-8.
8
Combined inhibition of RAC1 and Bcl-2/Bcl-xL synergistically induces glioblastoma cell death through down-regulation of the Usp9X/Mcl-1 axis.联合抑制 RAC1 和 Bcl-2/Bcl-xL 通过下调 Usp9X/Mcl-1 轴协同诱导胶质母细胞瘤细胞死亡。
Cell Oncol (Dordr). 2019 Jun;42(3):287-301. doi: 10.1007/s13402-019-00425-3. Epub 2019 Mar 11.
9
CircPITX1 Regulates Proliferation, Angiogenesis, Migration, Invasion, and Cell Cycle of Human Glioblastoma Cells by Targeting miR-584-5p/KPNB1 Axis.环状 RNA PITX1 通过靶向 miR-584-5p/KPNB1 轴调控人脑胶质瘤细胞的增殖、血管生成、迁移、侵袭和细胞周期。
J Mol Neurosci. 2021 Aug;71(8):1683-1695. doi: 10.1007/s12031-021-01820-y. Epub 2021 Mar 24.
10
The p53 upregulated modulator of apoptosis (PUMA) chemosensitizes intrinsically resistant ovarian cancer cells to cisplatin by lowering the threshold set by Bcl-x(L) and Mcl-1.p53 上调凋亡调节剂(PUMA)通过降低 Bcl-x(L) 和 Mcl-1 设置的阈值使顺铂对内在耐药的卵巢癌细胞增敏。
Mol Med. 2011;17(11-12):1262-74. doi: 10.2119/molmed.2011.00176. Epub 2011 Aug 19.

引用本文的文献

1
The function of PCSK9 in doxorubicin-induced cardiotoxicity and its underlying mechanism.前蛋白转化酶枯草溶菌素9(PCSK9)在阿霉素诱导的心脏毒性中的作用及其潜在机制。
Sci Rep. 2025 Jul 1;15(1):22067. doi: 10.1038/s41598-025-03419-4.
2
Activation of Unfolded Protein Response Pathway in Malignancies: Interplay with Extracellular Matrix and Targeting Perspectives.恶性肿瘤中未折叠蛋白反应途径的激活:与细胞外基质的相互作用及靶向治疗前景
Cancers (Basel). 2025 Jun 13;17(12):1972. doi: 10.3390/cancers17121972.
3
VCP's nuclear journey: Initiated by interacting with KPNB1 to repair DNA damage.

本文引用的文献

1
Measurement of BH3-only protein tolerance.BH3 仅蛋白耐受度的测量。
Cell Death Differ. 2018 Feb;25(2):282-293. doi: 10.1038/cdd.2017.156. Epub 2017 Oct 20.
2
Targeting BCL-2-like Proteins to Kill Cancer Cells.靶向BCL-2样蛋白以杀死癌细胞。
Trends Cancer. 2016 Aug;2(8):443-460. doi: 10.1016/j.trecan.2016.07.001. Epub 2016 Jul 30.
3
Targeting the Nuclear Import Receptor Kpnβ1 as an Anticancer Therapeutic.靶向核输入受体Kpnβ1作为一种抗癌疗法。
VCP的核内进程:通过与核转运蛋白β1相互作用启动以修复DNA损伤。
Proc Natl Acad Sci U S A. 2025 May 13;122(19):e2416045122. doi: 10.1073/pnas.2416045122. Epub 2025 May 8.
4
Silencing of spindle apparatus coiled-coil protein 1 suppressed the progression of hepatocellular carcinoma through farnesyltransferase-beta and increased drug sensitivity.纺锤体装置卷曲螺旋蛋白1的沉默通过法尼基转移酶-β抑制肝细胞癌进展并增加药物敏感性。
Heliyon. 2024 Jul 14;10(14):e34484. doi: 10.1016/j.heliyon.2024.e34484. eCollection 2024 Jul 30.
5
Survival-Related Genes on Chromosomes 6 and 17 in Medulloblastoma.染色体 6 和 17 上与生存相关的神经母细胞瘤基因。
Int J Mol Sci. 2024 Jul 9;25(14):7506. doi: 10.3390/ijms25147506.
6
Astragaloside Ⅳ mediates the effect and mechanism of KPNB1 on biological behavior and tumor growth in prostate cancer.黄芪甲苷Ⅳ介导核转运蛋白β1对前列腺癌生物学行为及肿瘤生长的影响及机制。
Heliyon. 2024 Jun 28;10(13):e33904. doi: 10.1016/j.heliyon.2024.e33904. eCollection 2024 Jul 15.
7
Recent Insights into the Angioregulatory Role of Long Non-coding RNAs and Circular RNAs in Gliomas: From Signaling Pathways to Clinical Aspects.长链非编码RNA和环状RNA在胶质瘤血管调节作用中的最新见解:从信号通路到临床层面
Curr Med Chem. 2024 Jan 22. doi: 10.2174/0109298673259378231031061149.
8
Stabilization of KPNB1 by deubiquitinase USP7 promotes glioblastoma progression through the YBX1-NLGN3 axis.去泛素化酶 USP7 通过稳定 KPNB1 促进神经胶质瘤的进展通过 YBX1-NLGN3 轴。
J Exp Clin Cancer Res. 2024 Jan 23;43(1):28. doi: 10.1186/s13046-024-02954-8.
9
ADAMTS-1 has nuclear localization in cells with epithelial origin and leads to decreased cell migration.ADAMTS-1 具有上皮来源细胞的核定位,并导致细胞迁移减少。
Exp Cell Res. 2023 Dec 15;433(2):113852. doi: 10.1016/j.yexcr.2023.113852. Epub 2023 Nov 10.
10
Therapeutic targeting of nuclear export and import receptors in cancer and their potential in combination chemotherapy.治疗性靶向核输出和进口受体在癌症及其在联合化疗中的潜力。
IUBMB Life. 2024 Jan;76(1):4-25. doi: 10.1002/iub.2773. Epub 2023 Aug 25.
Mol Cancer Ther. 2016 Apr;15(4):560-73. doi: 10.1158/1535-7163.MCT-15-0052. Epub 2016 Feb 1.
4
ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development.处于临床开发阶段的ABT-199(维奈托克)及BCL-2抑制剂
J Hematol Oncol. 2015 Nov 20;8:129. doi: 10.1186/s13045-015-0224-3.
5
Targeting BCL2-Proteins for the Treatment of Solid Tumours.靶向BCL2蛋白治疗实体瘤
Adv Med. 2014;2014:943648. doi: 10.1155/2014/943648. Epub 2014 Aug 27.
6
Upregulation of nuclear transporter, Kpnβ1, contributes to accelerated cell proliferation- and cell adhesion-mediated drug resistance (CAM-DR) in diffuse large B-cell lymphoma.核转运蛋白Kpnβ1的上调促进弥漫性大B细胞淋巴瘤中细胞增殖加速和细胞黏附介导的耐药性(CAM-DR)。
J Cancer Res Clin Oncol. 2016 Mar;142(3):561-72. doi: 10.1007/s00432-015-2057-4. Epub 2015 Oct 23.
7
ER stress: Autophagy induction, inhibition and selection.内质网应激:自噬的诱导、抑制与选择
Autophagy. 2015 Nov 2;11(11):1956-1977. doi: 10.1080/15548627.2015.1091141.
8
Hyper-dependence of breast cancer cell types on the nuclear transporter Importin β1.乳腺癌细胞类型对核转运蛋白输入蛋白β1的高度依赖性。
Biochim Biophys Acta. 2015 Aug;1853(8):1870-8. doi: 10.1016/j.bbamcr.2015.05.002. Epub 2015 May 8.
9
CHOP mediates XBP1S-induced renal mesangial cell necrosis following high glucose treatment.CHOP 介导高糖处理后 XBP1S 诱导的肾系膜细胞坏死。
Eur J Pharmacol. 2015 Jul 5;758:89-96. doi: 10.1016/j.ejphar.2015.03.069. Epub 2015 Apr 6.
10
Suppression of the nuclear transporter-KPNβ1 expression inhibits tumor proliferation in hepatocellular carcinoma.抑制核转运蛋白-KPNβ1的表达可抑制肝细胞癌的肿瘤增殖。
Med Oncol. 2015 Apr;32(4):128. doi: 10.1007/s12032-015-0559-1. Epub 2015 Mar 21.